Bellevue Life Sciences Ac... (BLAC)
NASDAQ: BLAC
· Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM
Bellevue Life Sciences Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 761.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 592.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 168.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -5.99M | -3.52M | -2.24M | -2.2M | -2M | -1.83M | -982.25K | -592.27K | -313.26K | -35.39K | -21.46K | -1.55K | -3.31K | -3.31K | -2.99K | -2.87K | -124 |
Interest Income | -473.97K | 2.53K | 2.14M | 2.49M | 2.84M | 2.78M | 1.85M | 1.23M | 417.73K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.54M | -2.11M | -98.13K | 294.94K | 835.01K | 944.59K | 863.47K | 635.38K | 104.36K | -35.39K | -21.46K | -1.55K | -3.31K | -3.31K | -2.99K | -2.87K | -124 |
Net Income | -13.74M | -2.41M | -474.9K | -165.71K | 233.04K | 403.78K | 475.7K | 377.5K | 75.04K | -35.39K | -21.46K | -1.55K | -3.31K | -3.31K | -2.99K | -2.87K | -124 |
Selling & General & Admin | 6.16M | 3.52M | 2.24M | 2.2M | 2M | 1.83M | 983.06K | 592.65K | 313.36K | 35.39K | 21.46K | 1.55K | 3.31K | 3.31K | 2.99K | 2.87K | 124.00 |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.16M | 3.52M | 2.24M | 2.2M | 2M | 1.83M | 983.06K | 592.65K | 313.36K | 35.39K | 21.46K | 1.55K | 3.31K | 3.31K | 2.99K | 2.87K | 124.00 |
Interest Expense | -59.41K | -43.01K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.75M | 3.52M | 2.24M | 2.2M | 2M | 1.83M | 983.06K | 592.65K | 313.36K | 35.39K | 21.46K | 1.55K | 3.31K | 3.31K | 2.99K | 2.87K | 124.00 |
Income Tax Expense | -385.71K | -295.24K | 376.8K | 460.65K | 601.96K | 540.81K | 387.77K | 257.89K | 29.32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.48M | 4.48M | 4.04M | 4.04M | 5.62M | 7.41M | 9.05M | 9.05M | 9.05M | 9.05M | 7.93M | 7.93M | 7.93M | 7.89M | 7.93M | 7.89M | 7.89M |
Shares Outstanding (Diluted) | 4.48M | 4.48M | 4.04M | 4.04M | 5.62M | 7.41M | 9.05M | 9.05M | 9.05M | 9.05M | 7.93M | 7.93M | 7.93M | 7.89M | 7.93M | 7.89M | 7.89M |
EPS (Basic) | -3.07 | -0.54 | -0.1 | -0.04 | 0.02 | 0.04 | 0.05 | 0.04 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | n/a |
EPS (Diluted) | -3.07 | -0.54 | -0.1 | -0.04 | 0.02 | 0.04 | 0.05 | 0.04 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | n/a |
EBITDA | -6.48M | -4.01M | -2.24M | -2.2M | -2M | -1.83M | -982.25K | -592.27K | -313.26K | -35.39K | -21.46K | -1.55K | -3.31K | -3.31K | -2.99K | -2.87K | -124 |
EBIT | 450K | -1K | -2.24M | -2.2M | -2M | -1.83M | -982.25K | -592.27K | -313.26K | -35.39K | -21.46K | -1.55K | -3.31K | -3.31K | -2.99K | -2.87K | -124 |
Depreciation & Amortization | -43.28K | n/a | 87.09K | 47.5K | 169.59K | 167.9K | 145.22K | 211.89K | 89.8K | 48.22K | 27.08K | n/a | n/a | n/a | n/a | n/a | n/a |